Bicycle Therapeutics Announces Gross Proceeds of $50.0 Million from its At-the-Market Offering Program and Enters into Debt Financing from Hercules Capital October 2, 2020
Momenta Pharmaceuticals, founded by Christoph Westphal as CEO, Announces Completion of Proposed Sale to Johnson & Johnson October 1, 2020
Millendo Therapeutics Announces Initiation of First-in-Human Clinical Trial of MLE-301, a Selective NK3R Antagonist September 25, 2020
Calithera Biosciences Initiates KEAPSAKE Randomized Phase 2 Trial of Telaglenastat in Combination with Chemoimmunotherapy to Treat Aggressive Form of Lung Cancer September 25, 2020
